TrialTargeted oncology2026

Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study.

Alba Rubio-San-Simón et al.PubMed ↗Publisher ↗

No numbers read from the abstract.